查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1755898

2032 年行动心电图设备市场预测：按产品类型、连接性、分销管道、技术、应用、最终用户和地区进行的全球分析

Mobile ECG Devices Market Forecasts to 2032 - Global Analysis By Product Type, Connectivity, Distribution Channel, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球行动心电图设备市场预计在 2025 年达到 46 亿美元，到 2032 年将达到 103 亿美元，预测期内的复合年增长率为 12.2%。

行动心电图设备是可携式心电图监控系统，旨在即时追踪心臟活动。这些紧凑型设备采用先进的传感器检测电信号，无需就诊即可进行远端心臟评估。它们支持早期发现心律不整和心律不齐，从而提升患者便利性和预防性医疗保健。行动心电图设备整合无线技术，可将资料无缝传输给医疗专业人员，以便及时分析。

根据心律学会发表的报导，心房颤动是最常见的心律不整之一，影响全球约4,000万人，其中包括美国约600万人。

全球心血管疾病（CVD）盛行率不断上升

由于人口老化和生活方式因素，心臟相关疾病日益普遍，对高效即时监测解决方案的需求也日益增长。行动心电图设备可让使用者远端追踪心臟活动，从而实现主动的医疗保健管理，减少就诊次数和紧急干预。这些设备在早期发现和预防方面发挥关键作用，有助于及时进行医疗干预，并改善患者预后。

资料隐私和安全问题

由于这些设备收集敏感的健康信息，确保安全传输和储存仍然是一项关键挑战。网路安全风险（包括未授权存取和资料外洩）威胁着病患的隐私。遵守严格的监管要求增加了实施的复杂性，并需要强大的加密和身份验证通讯协定，从而阻碍了市场的成长。

整合人工智慧和机器学习

人工智慧主导的演算法能够即时识别细微的心律不整，从而提高诊断准确性，减少假阳性并改善临床决策。预测分析能够进行早期风险评估，并帮助医疗专业人员根据持续监测数据制定个人化治疗方案。人工智慧心电图解决方案能够简化工作流程，提高效率，优化远距病患管理，进而降低医疗成本。

非专家对数据的误解

非专业使用者误读资料的风险，对有效使用行动心电图设备构成了重大挑战。虽然此类设备能够增强自我监测能力，但错误的读数和不准确的分析可能会导致不必要的担忧和症状的忽视。未经医学训练的使用者可能难以正确解读结果，从而延误重要治疗或引起过度焦虑，阻碍市场成长。

COVID-19的影响

疫情加速了行动心电图设备的普及，因为医疗保健系统优先考虑对患者的远端监控，以减少就诊次数并最大程度地降低暴露风险。远端医疗和数位健康平台的兴起增加了对穿戴式和可携式心电图解决方案的需求。虽然供应链中断最初影响了生产，但由于对数位医疗基础设施的投资增加，市场已经反弹。

手持式心电图设备市场预计将在预测期内实现最大幅度成长

手持式心电图设备凭藉其便携性和易用性，预计在预测期内将占据最大的市场占有率。这些小型设备能够快速评估心臟状况，因此在临床和个人应用中都具有很高的价值。与智慧型手机和云端基础系统的整合增强了可存取性和远端资料传输。手持式心电图设备在医疗保健专业人士和消费者中的广泛应用凸显了其在预防性医疗保健中的重要性，从而增加了对高效且用户友好的心臟监测解决方案的需求。

预计心律不整监测部分在预测期内将达到最高的复合年增长率。

由于人们越来越重视早期检测和持续的心臟健康追踪，预计心律不整监测领域将在预测期内实现最高成长率。具有主导的心律不整检测功能的行动心电图设备将提高诊断准确性，并支援及时的医疗介入。感测器技术和穿戴式装置整合的进步将有助于实现无缝监测，使用户能够有效地追踪心率。

比最大的地区

在预测期内，亚太地区预计将占据最大的市场占有率，这得益于医疗保健意识的提升、数位健康倡议的不断扩展以及人口老龄化。政府对医疗技术的投入以及消费者对穿戴式心电图设备的日益普及正在推动市场的发展。快速的都市化和心血管疾病的流行进一步推动了该地区对行动心电图解决方案的需求。

复合年增长率最高的地区

在预测期内，北美预计将呈现最高的复合年增长率，这得益于技术进步、人工智慧主导的诊断技术以及强大的医疗基础设施。该地区对远端医疗和远端患者监护的关注加速了行动心电图设备的普及，因为它们在预防性心臟护理中发挥关键作用。凭藉其支持性的法律规范和对数位医疗创新的大量投资，上述因素使北美成为心电图设备开发和部署的主要枢纽。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场参与企业（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家进行市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 透过产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 二手研究资料
    • 先决条件

第三章市场走势分析

  • 介绍
  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

第五章全球行动心电图设备市场（依产品类型）

  • 介绍
  • 手持式心电图设备
  • 穿戴式心电图设备
  • 笔式心电图仪
  • 其他的

6. 全球行动心电图设备市场-按连线类型

  • 介绍
  • Bluetooth
  • Wi-Fi
  • USB
  • 行动电话网络

7. 全球行动心电图设备市场（依通路）

  • 介绍
  • 线上平台
  • 药局
  • 医疗设备经销商
  • 医院/诊所供应链

8. 全球行动心电图设备市场（按技术）

  • 介绍
  • 单导联心电图
  • 三导联心电图
  • 6导联心电图
  • 12导联心电图

9. 全球行动心电图设备市场（依应用）

  • 介绍
  • 心律不整监测
  • 心房颤动检测
  • 心率监测
  • 心臟缺血监测
  • 其他的

第 10 章全球行动心电图设备市场（依最终用户）

  • 介绍
  • 医院和诊所
  • 居家照护
  • 门诊手术中心
  • 个人使用者/患者
  • 诊断中心
  • 其他的

第 11 章全球行动心电图设备市场（按地区）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十二章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司概况

  • Apple Inc.
  • AliveCor Inc.
  • Bittium Corporation
  • CardioComm Solutions Inc.
  • GE Healthcare
  • Hillrom Holdings Inc.
  • iRhythm Technologies Inc.
  • Medtronic plc
  • Nihon Kohden Corporation
  • Omron Healthcare Inc.
  • Philips Healthcare
  • Qardio Inc.
  • Schiller AG
  • VitalConnect Inc.
  • Beurer GmbH
  • BPL Medical Technologies
  • Edan Instruments Inc.
  • Withings SA
Product Code: SMRC29792

According to Stratistics MRC, the Global Mobile ECG Devices Market is accounted for $4.6 billion in 2025 and is expected to reach $10.3 billion by 2032 growing at a CAGR of 12.2% during the forecast period. Mobile ECG devices are portable electrocardiogram monitoring systems designed to track heart activity in real time. These compact devices use advanced sensors to detect electrical signals, enabling remote cardiac assessments without clinical visits. They support early detection of arrhythmias and heart irregularities, enhancing patient convenience and preventive healthcare. Integrated with wireless technology, mobile ECGs offer seamless data transmission to medical professionals for timely analysis.

According to article published by the Heart Rhythm Society, atrial fibrillation is one of the most common types of cardiac arrhythmia and affects around 40 million people globally. In addition, the condition affects approximately 6 million people in the U.S.

Market Dynamics:

Driver:

Increasing global incidence of cardiovascular diseases (CVDs)

Heart-related conditions becoming more prevalent due to aging populations and lifestyle factors, the need for efficient, real-time monitoring solutions is increasing. Mobile ECG devices enable proactive healthcare management by allowing users to track heart activity remotely, reducing hospital visits and emergency interventions. These devices play a vital role in early detection and prevention, facilitating timely medical intervention and improving patient outcomes.

Restraint:

Data privacy and security concerns

As these devices collect sensitive health information, ensuring secure transmission and storage remains a critical issue. Cybersecurity risks, including unauthorized access and data breaches, pose threats to patient confidentiality. Compliance with stringent regulatory requirements adds complexity to implementation, requiring robust encryption and authentication protocols hampers the market growth.

Opportunity:

Integration with AI and machine learning

AI-driven algorithms enhance diagnostic accuracy by identifying subtle cardiac irregularities in real-time, reducing false readings and improving clinical decision-making. Predictive analytics enable early risk assessment, helping healthcare professionals tailor personalized treatment plans based on continuous monitoring data. AI-powered ECG solutions streamline workflow efficiency, optimizing remote patient management and reducing healthcare costs.

Threat:

Misinterpretation of data by non-professionals

The risk of data misinterpretation by non-professional users poses a significant challenge to the effective use of mobile ECG devices. While these devices empower individuals with self-monitoring capabilities, improper readings or inaccurate analysis may lead to unnecessary concern or overlooked symptoms. Users without medical training may struggle to interpret results correctly, potentially delaying crucial treatment or causing unwarranted anxiety impeding the market growth.

Covid-19 Impact:

The pandemic accelerated the adoption of mobile ECG devices as healthcare systems prioritized remote patient monitoring to reduce hospital visits and minimize exposure risks. Telemedicine and digital health platforms became more prevalent, driving demand for wearable and portable ECG solutions. Supply chain disruptions initially affected production, but increased investment in digital healthcare infrastructure led to market recovery.

The handheld ECG devices segment is expected to be the largest during the forecast period

The handheld ECG devices segment is expected to account for the largest market share during the forecast period due to their portability and ease of use. These compact devices provide quick cardiac assessments, making them highly valuable for both clinical and personal applications. Their integration with smartphones and cloud-based systems enhances accessibility and remote data transmission. Widespread adoption among healthcare professionals and consumers underscores their importance in preventive care, driving demand for efficient and user-friendly cardiac monitoring solutions.

The arrhythmia monitoring segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the arrhythmia monitoring segment is predicted to witness the highest growth rate fueled by the growing emphasis on early detection and continuous heart health tracking. Mobile ECG devices equipped with AI-driven arrhythmia detection capabilities enhance diagnostic accuracy, supporting timely medical intervention. Advancements in sensor technology and wearable integrations contribute to seamless monitoring, allowing users to track heart rhythm irregularities efficiently.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share driven by increasing healthcare awareness, expanding digital health initiatives, and a growing aging population. Government investments in medical technology and rising consumer adoption of wearable ECG devices contribute to market leadership. Rapid urbanization and the prevalence of cardiovascular conditions further support regional demand for mobile ECG solutions.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR propelled by technological advancements, AI-driven diagnostics, and robust healthcare infrastructure. The region's strong focus on telemedicine and remote patient monitoring accelerates adoption, as mobile ECG devices play a vital role in preventive cardiac care. Supportive regulatory frameworks and significant investments in digital healthcare innovations reinforce This aforementioned factors position North America as a leading hub for ECG device development and deployment.

Key players in the market

Some of the key players in Mobile ECG Devices Market include Apple Inc., AliveCor Inc., Bittium Corporation, CardioComm Solutions Inc., GE Healthcare, Hillrom Holdings Inc., iRhythm Technologies Inc., Medtronic plc, Nihon Kohden Corporation, Omron Healthcare Inc., Philips Healthcare, Qardio Inc., Schiller AG, VitalConnect Inc., Beurer GmbH, BPL Medical Technologies, Edan Instruments Inc., and Withings SA.

Key Developments:

In May 2025, AliveCor introduced the KardiaMobile 6L Max and KardiaAlert, its most advanced personal ECG system yet, bringing enhanced AI-powered 6-lead monitoring for consumers and clinicians. This launch strengthens its position in digital cardiac care by offering real-time alerts and enhanced diagnostic reach

In May 2025, iRhythm rolled out its Zio long-term ECG recording and analysis service in Japan, expanding its AI-powered arrhythmia detection platform into Asian markets. This launch marks a major international expansion for its digital health offerings.

In May 2025, AliveCor teamed up with AI-health startup Anumana to integrate advanced FDA-cleared LEF detection algorithms into Kardia devices for early cardiac disease screening. This collaboration enhances clinical intelligence and paves the way for next-generation AI-enabled ECG diagnostics.

Product Types Covered:

  • Handheld ECG Devices
  • Wearable ECG Devices
  • Pen-type ECG Devices
  • Other Product Types

Connectivities Covered:

  • Bluetooth
  • Wi-Fi
  • USB
  • Cellular Network

Distribution Channels Covered:

  • Online Platforms
  • Pharmacies
  • Medical Device Stores
  • Hospital/Clinic Supply Chains

Technologies Covered:

  • Single-Lead ECG
  • 3-Lead ECG
  • 6-Lead ECG
  • 12-Lead ECG

Applications Covered:

  • Arrhythmia Monitoring
  • Atrial Fibrillation Detection
  • Heart Rate Monitoring
  • Cardiac Ischemia Monitoring
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Individual Users/Patients
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Mobile ECG Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Handheld ECG Devices
  • 5.3 Wearable ECG Devices
  • 5.4 Pen-type ECG Devices
  • 5.5 Other Product Types

6 Global Mobile ECG Devices Market, By Connectivity

  • 6.1 Introduction
  • 6.2 Bluetooth
  • 6.3 Wi-Fi
  • 6.4 USB
  • 6.5 Cellular Network

7 Global Mobile ECG Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Online Platforms
  • 7.3 Pharmacies
  • 7.4 Medical Device Stores
  • 7.5 Hospital/Clinic Supply Chains

8 Global Mobile ECG Devices Market, By Technology

  • 8.1 Introduction
  • 8.2 Single-Lead ECG
  • 8.3 3-Lead ECG
  • 8.4 6-Lead ECG
  • 8.5 12-Lead ECG

9 Global Mobile ECG Devices Market, By Application

  • 9.1 Introduction
  • 9.2 Arrhythmia Monitoring
  • 9.3 Atrial Fibrillation Detection
  • 9.4 Heart Rate Monitoring
  • 9.5 Cardiac Ischemia Monitoring
  • 9.6 Other Applications

10 Global Mobile ECG Devices Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals & Clinics
  • 10.3 Home Care Settings
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Individual Users/Patients
  • 10.6 Diagnostic Centers
  • 10.7 Other End Users

11 Global Mobile ECG Devices Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Apple Inc.
  • 13.2 AliveCor Inc.
  • 13.3 Bittium Corporation
  • 13.4 CardioComm Solutions Inc.
  • 13.5 GE Healthcare
  • 13.6 Hillrom Holdings Inc.
  • 13.7 iRhythm Technologies Inc.
  • 13.8 Medtronic plc
  • 13.9 Nihon Kohden Corporation
  • 13.10 Omron Healthcare Inc.
  • 13.11 Philips Healthcare
  • 13.12 Qardio Inc.
  • 13.13 Schiller AG
  • 13.14 VitalConnect Inc.
  • 13.15 Beurer GmbH
  • 13.16 BPL Medical Technologies
  • 13.17 Edan Instruments Inc.
  • 13.18 Withings SA

List of Tables

  • Table 1 Global Mobile ECG Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Mobile ECG Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Mobile ECG Devices Market Outlook, By Handheld ECG Devices (2024-2032) ($MN)
  • Table 4 Global Mobile ECG Devices Market Outlook, By Wearable ECG Devices (2024-2032) ($MN)
  • Table 5 Global Mobile ECG Devices Market Outlook, By Pen-type ECG Devices (2024-2032) ($MN)
  • Table 6 Global Mobile ECG Devices Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 7 Global Mobile ECG Devices Market Outlook, By Connectivity (2024-2032) ($MN)
  • Table 8 Global Mobile ECG Devices Market Outlook, By Bluetooth (2024-2032) ($MN)
  • Table 9 Global Mobile ECG Devices Market Outlook, By Wi-Fi (2024-2032) ($MN)
  • Table 10 Global Mobile ECG Devices Market Outlook, By USB (2024-2032) ($MN)
  • Table 11 Global Mobile ECG Devices Market Outlook, By Cellular Network (2024-2032) ($MN)
  • Table 12 Global Mobile ECG Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 13 Global Mobile ECG Devices Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 14 Global Mobile ECG Devices Market Outlook, By Pharmacies (2024-2032) ($MN)
  • Table 15 Global Mobile ECG Devices Market Outlook, By Medical Device Stores (2024-2032) ($MN)
  • Table 16 Global Mobile ECG Devices Market Outlook, By Hospital/Clinic Supply Chains (2024-2032) ($MN)
  • Table 17 Global Mobile ECG Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 18 Global Mobile ECG Devices Market Outlook, By Single-Lead ECG (2024-2032) ($MN)
  • Table 19 Global Mobile ECG Devices Market Outlook, By 3-Lead ECG (2024-2032) ($MN)
  • Table 20 Global Mobile ECG Devices Market Outlook, By 6-Lead ECG (2024-2032) ($MN)
  • Table 21 Global Mobile ECG Devices Market Outlook, By 12-Lead ECG (2024-2032) ($MN)
  • Table 22 Global Mobile ECG Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 23 Global Mobile ECG Devices Market Outlook, By Arrhythmia Monitoring (2024-2032) ($MN)
  • Table 24 Global Mobile ECG Devices Market Outlook, By Atrial Fibrillation Detection (2024-2032) ($MN)
  • Table 25 Global Mobile ECG Devices Market Outlook, By Heart Rate Monitoring (2024-2032) ($MN)
  • Table 26 Global Mobile ECG Devices Market Outlook, By Cardiac Ischemia Monitoring (2024-2032) ($MN)
  • Table 27 Global Mobile ECG Devices Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 28 Global Mobile ECG Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 29 Global Mobile ECG Devices Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 30 Global Mobile ECG Devices Market Outlook, By Home Care Settings (2024-2032) ($MN)
  • Table 31 Global Mobile ECG Devices Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 32 Global Mobile ECG Devices Market Outlook, By Individual Users/Patients (2024-2032) ($MN)
  • Table 33 Global Mobile ECG Devices Market Outlook, By Diagnostic Centers (2024-2032) ($MN)
  • Table 34 Global Mobile ECG Devices Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.